US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Sigyn Therapeutics Inc (QB) (SIGY)
Sigyn Therapeutics Inc (QB) (SIGY) ニュース

SIGY

Sigyn Therapeutics (QB) (SIGY)

Sigyn Therapeutics Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:SIGY

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/01	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2024/01/31	06 : 23	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2024/01/12	05 : 25	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2024/01/09	04 : 34	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/12/13	04 : 48	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/10/27	04 : 23	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/10/05	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/09/20	04 : 56	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/08/15	04 : 35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/07/08	00 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/06/09	03 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/05/17	20 : 15	InvestorsHub NewsWire	Sigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark Application	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/05/16	06 : 35	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/05/11	06 : 27	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/03/31	23 : 06	InvestorsHub NewsWire	Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/03/31	19 : 19	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2023/03/01	05 : 19	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/12/24	05 : 52	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/11/15	05 : 51	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/09/15	01 : 37	InvestorsHub NewsWire	Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/08/30	19 : 09	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/08/15	19 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/08/03	20 : 07	InvestorsHub NewsWire	Sigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/06/23	19 : 02	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/05/23	18 : 00	TipRanks	Analysts Are Bullish on These Healthcare Stocks: Sigyn Therapeutics (SIGY)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/03/22	06 : 29	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/03/02	07 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2022/02/05	00 : 48	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2021/12/17	22 : 48	InvestorsHub NewsWire	Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or Vaccines	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
2021/11/13	06 : 49	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)

Showing the most relevant articles for your search:USOTC:SIGY

DeltaChain Token

Angstrom Technologies (PK)

INTESA SANPAOLO

Amplify Travel Tech ETF

Amundi Asset Management

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約